Veterinary Medicines

Interclox DC Intramammary Suspension

Authorised
  • Cloxacillin hemibenzathine
  • Ampicillin trihydrate
Download as PDF

Product identification

Medicine name:
Interclox DC Intramammary Suspension
Active substance:
  • Cloxacillin hemibenzathine
  • Ampicillin trihydrate
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cloxacillin hemibenzathine
    1275.64
    milligram(s)
    /
    1.00
    Syringe
  • Ampicillin trihydrate
    288.71
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        120
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 4.5 g single dose white polyethylene, self-venting click-lock syringes.Supplied in cartons of 80 syringes.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chem-Pharm (Ballyvaughan) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10823/011/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 2/03/2025
Download